Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

32.8K
Overview
32.8K
Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

1.3K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.2K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

756
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
756
Immunological Memory01:23

Immunological Memory

14.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Vaccine Adverse Events Between Zoster Vaccine Live and Recombinant Zoster Vaccine: A Prospective Multicenter Survey.

Journal of Korean medical science·2026
Same author

Limited protective immunity to respiratory syncytial virus and pertussis among adults and healthcare workers in South Korea: A seroepidemiologic study.

Human vaccines & immunotherapeutics·2026
Same author

Development and Validation of Sixplexed Opsonophagocytic Killing Assay for Serotype-Specific Functional Pneumococcal Antibody Measurement.

Vaccines·2026
Same author

Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Broad Protection Against Streptococcus suis Infection.

The Journal of infectious diseases·2026
Same author

Real-World Effectiveness of Seasonal Influenza Vaccines During the 2024-2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method.

Vaccines·2026
Same author

Establishing an Active Vaccine Safety Surveillance System Using Large Scale Databases in Korea: Lessons and Scalable Insights for Global Application.

Journal of Korean medical science·2026

Related Experiment Video

Updated: Jan 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Cross-reactive immunity within pneumococcal serogroups: Implications for next-generation vaccine development.

A-Yeung Jang1, Hyun Jung Ji2, Eun Hye Kang3

  • 1Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of Korea.

Vaccine
|December 31, 2025
PubMed
Summary

Pneumococcal vaccines elicit varied cross-reactive immunity within serogroups. Understanding these patterns, like serogroup 6A protecting against 6B/6C, is key for designing next-generation pneumococcal vaccines.

Keywords:
Cross-reactive immunogenicityPneumococcal vaccinePneumococcusSerogroupSerotype replacement

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.5K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

46.5K

Related Experiment Videos

Last Updated: Jan 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.5K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

46.5K

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Pneumococcal serotype replacement dynamics influence vaccine efficacy.
  • Understanding cross-reactive immunity is crucial for next-generation pneumococcal vaccine design.

Purpose of the Study:

  • To investigate within-serogroup cross-reactive immunity among pneumococcal serotypes using inhibition opsonophagocytic assays (OPA).
  • To provide immunologic insights into serotype-replacement dynamics.

Main Methods:

  • Pooled sera from adults aged ≥40 years, vaccinated with PCV13/PPSV23, PCV20, or PCV21, were used.
  • Cross-reactivity was assessed across serogroups 6, 9, 15, 19, and 23 via inhibition OPA.
  • Residual OPA titers were measured after adsorption with homologous or heterologous inactivated pneumococcal strains.

Main Results:

  • Cross-reactivity varied significantly by serogroup.
  • Serogroup 6A demonstrated broad cross-protection against 6B and 6C, while 6D showed only homologous reactivity.
  • Inhibition OPA revealed inconsistent cross-reactivity within serogroup 15 and partial, asymmetric cross-reactivity between 19A and 19F; serogroups 9 and 23 showed negligible cross-reactivity.

Conclusions:

  • Inhibition OPA precisely assessed serogroup-level cross-reactive immunity, highlighting heterogeneous patterns.
  • Findings emphasize the need for careful serotype selection and epitope evaluation in future pneumococcal vaccine development.